Literature DB >> 865584

Biochemical profile or uremic breath.

M L Simenhoff, J F Burke, J J Saukkonen, A T Ordinario, R Doty.   

Abstract

We attempted to define the substances that contribute to the characteristic "uremic breath" of patients with end-stage renal disease. Breath samples from nine patients underwent direct analysis before and after hemodialysis with use of gas chromatography and confirmation by mass spectrometry, and indirectly assessment by an organoleptic panel. Concentrations of secondary and tertiary amines, dimethylamine and trimethylamine were increased, with subsequent reduction after hemodialysis (dimethylamine from 2.00 +/- 0.19 [S.E.M.] to 0.88 +/- 0.12 microng per 30 minutes, P less than 0.001, and trimethylamine from 0.79 +/- 0.22 to 0.44 +/- 0.15 microng per 30 minutes, P less than 0.003). Treatment with nonabsorbable antibiotics in two patients reduced both serum and breath amine levels without dialysis. Loss of nitrogen via the breath was not quantitatively important. We conclude that uremic breath reflects the systemic accumulation of potentially toxic volatile metabolites, among which dimethylamine and trimethylamine have been positively identified and correlated with the classic fishy odor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 865584     DOI: 10.1056/NEJM197707212970303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

2.  Microcantilevers modified by specific peptide for selective detection of trimethylamine.

Authors:  Xin Huang; Mingfu Li; Xiaohe Xu; Hongjun Chen; Hai-Feng Ji; Shuifang Zhu
Journal:  Biosens Bioelectron       Date:  2011-09-16       Impact factor: 10.618

Review 3.  Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease.

Authors:  J David Spence
Journal:  J Transl Int Med       Date:  2016-04-14

Review 4.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

5.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

6.  On the importance of statistics in breath analysis--hope or curse?

Authors:  Sandrah P Eckel; Jan Baumbach; Anne-Christin Hauschild
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

Review 7.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

8.  In vitro metabolism of creatinine, methylamine and amino acids by intestinal contents of normal and uraemic subjects.

Authors:  C W Owens; Z P Albuquerque; G M Tomlinson
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

9.  Halitosis and Helicobacter pylori: a possible relationship.

Authors:  E Ierardi; A Amoruso; T La Notte; R Francavilla; S Castellaneta; E Marrazza; R A Monno; A Francavilla
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

10.  Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules.

Authors:  Amanda C Raff; Sung Lieu; Michal L Melamed; Zhe Quan; Manish Ponda; Timothy W Meyer; Thomas H Hostetter
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.